DailyIQ
Last updated 6 minutes ago

JBS·JBS N.V.

$.
+. (+.%)
After Hours
High
$11.95
Open
$11.86
Market Cap
12.73B
52W High
$18.65
Low
$11.61
P. Close
$11.90
P/E
7.29
52W Low
$11.49
Fwd P/E
6.78
DailyIQ Est.
$19.84
Technical Score (1D)
23
SELL
News Sentiment
-
NO DATA
JBS released its Q1 2026 earnings, detailing revenue, earnings, and operational metrics, and management outlined guidance for the remainder of the year, addressing cost pressures and margin expectations. Analysts focused on cost control and margin expansion, indicating that JBS is actively managing rising input costs, which could influence short‑term profitability. The company’s guidance suggests a cautious outlook for the rest of 2026, with expectations of continued cost pressures but potential margin improvement if operational efficiencies materialize. In the same timeframe, the Trump administration announced a $500 million aid package for smaller meatpackers, explicitly excluding JBS, which may widen the competitive gap and affect JBS’s cost structure. The exclusion could pressure JBS to absorb higher costs without the financial cushion available to smaller rivals, potentially tightening margins in the near term. Earlier analyst guidance maintained a Buy rating with an $18.2 target despite a 20 % drop in the US beef segment, underscoring confidence that the decline is temporary and driven by market volatility. JBS’s decision to shut several plants amid record beef prices reflects a strategic shift toward higher‑margin products, which may reduce overall production capacity and tighten supply, potentially supporting price levels. The recent screwworm outbreak in Texas, which has already impacted JBS and Tyson, highlights sector‑wide supply chain vulnerabilities that could increase costs and affect pricing. Finally, China’s halt of JBS imports and the Greenpeace lawsuit over expansion plans add regulatory and market risks that could constrain revenue streams and require diversification.
Earnings Summary
JBS N.V. is a global food company focused on protein production and distribution, offering a diversified portfolio that includes beef, poultry, pork, and plant‑based options, as well as leather products, positioning it as a major player in the packaged foods sector. In Q2 2025 the company reported earnings per share of $1.54 against an estimate of $2.63, a miss that reflects the impact of rising operating costs and supply‑chain constraints, while revenue reached $118.97 billion, a figure that, although robust, was not accompanied by an estimate for comparison. Data for Q4 2025 and Q2 2026 are incomplete, with only estimates available, limiting the ability to assess a clear acceleration or deceleration trend across the most recent quarters. Historical analysis is constrained by the paucity of actual results; the single quarter of EPS miss and strong revenue figure preclude a definitive trend assessment, though the company’s diversified mix suggests resilience. Recent news highlights that the Trump administration’s $500 million aid package for smaller meatpackers excluded JBS, potentially tightening its pricing power, while the company’s plant closures and a Texas screwworm outbreak add further supply‑chain risk; additionally, China’s import halt and a Greenpeace lawsuit introduce regulatory uncertainty that could weigh on future earnings. Forward‑looking watch points for investors include monitoring USDA pest‑containment advisories, updates on JBS’s cost‑control initiatives, the outcome of the Greenpeace lawsuit, and any changes in Chinese import policy that may influence export strategy, all of which will be critical for gauging the company’s near‑term trajectory.

EPS

EstBeatMiss
$1.38$1.73$2.08$2.44$2.79Q2'25Q4'25
QtrEstActual+/−
Q4'25$2.26 - -
Q2'25$2.63$1.54-41.3%

Revenue

EstBeatMiss
$117.6B$118.0B$118.4B$118.8B$119.2BQ2'25Q4'25
QtrEstActual+/−
Q4'25$117.8B - -
Q2'25 - $119.0B -

Market Data

JBS Stock Snapshot

JBS is currently trading at $11.91, giving JBS N.V. a market cap of 12.73B and a P/E ratio of 7.3. Today's range spans $11.61–$11.95, with shares opening at $11.86 and moving up $0.01 (0.1%) from the prior close. DailyIQ's technical score sits at 23/100 (SELL).

Over the past year JBS has traded between $11.49 and $18.65 - the current price is +3.7% off the 52-week low and -36.1% from the high. 19 analysts cover the stock with a Buy consensus and a mean 12-month target of $19.13 (range $15.30–$21.72), implying upside of +60.6%.

Earnings estimate risk is at the forefront for JBS N.V. (JBS) - a large-cap Consumer Defensive name (12.73B market cap) showing a SELL (23/100) alongside neutral sentiment (-/100) often flags a period where consensus estimates are still catching down to what the market is already pricing in. Price: $11.91 (near 52-week lows in $11.49–$18.65). (P/E: 7.3) Active managers who track the technical-fundamental gap tend to position ahead of the revision, not after it.

When a large-cap Consumer Defensive name with 12.73B in capitalization prints a SELL signal (23/100) alongside neutral news sentiment (-/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $11.91 (near 52-week lows in the $11.49–$18.65 range), the structural support levels are where that sponsorship question gets answered.